Being highly lipophilic, it is readily taken up by rare cells (such as myeloma cells) across the membrane barrier, leading to activation by hydrolytic cleavage of the peptide bond using peptidases and esterases overexpressed in multiple myeloma cells to release a toxic cargo into the cells, damaging the DNA and killing the cancer cells [58]. The gene discussed is LAP3; the disease is plasma cell myeloma.